"
Team:Westminster/Judging
From 2012.igem.org
<head>
<meta http-equiv="content-type" content="text/php; charset=utf-8" />
<style type="text/css"> @import url 'http://yui.yahooapis.com/2.9.0/build/reset/reset-min.css'; ul { list-style: none; } body { font-family: "HelveticaNeue-Light", "Helvetica Neue Light", "Helvetica Neue", Helvetica, Arial, "Lucida Grande", sans-serif; font-weight: 300; /* background: url("http://www.westminsterigem.com/files/theme/body-bg.png") repeat #ffffff;*/ background-color:#FFF; color: #666666;
} h1 { color: #ff0000; font-size: 18pt; margin-bottom: 0.5em; } p {
} a {
} #p-logo { background: #444444; } div#top-section, div#content { box-shadow: 0px 0px 17px -4px #666666; padding:0px; margin-top:0px;
} div#wrapper { position: relative; width: 100%; font-size: 12pt; margin: 0 auto; background: #ffffff; background-attachment: url('https://static.igem.org/mediawiki/2012/2/2e/Bg-tumours.png'); background-repeat: no-repeat;
padding:0px; margin-top:0px; top:0px;
} div#header { height: 120px; width: 100%; background-color:#000; background: url('https://static.igem.org/mediawiki/2012/2/2e/Bg-tumours.png'); background-repeat: no-repeat; z-index:10; position:relative; top:0px; left:0px; } div#header div#logo { position: relative; width: 260px; right:10px; top:-9px; float:right;
margin-bottom: 0px; /* height: 0px; margin: 0 auto;*/ } div#header div#logo a { float:left; display:block; margin-left:10px;
}
div#navigation {
width: 850px;
height: 27px;
background:rgba(0,0,0,.5);
float:left;
position:relative;
top:54px;
}
ul#navigation-list {
height: 27px;
line-height: 27px;
overflow: auto;
}
ul#navigation-list > li {
float: left;
margin-top:-5px;
}
ul#navigation-list > li > ul {
position: absolute;
display: none;
background: #000000;
z-index: 100000;
}
ul#navigation-list > li > ul.submenu {
margin: 0;
}
ul#navigation-list > li > ul.submenu li {
padding: 2px 0px;
}
ul#navigation-list a.navlink {
color: #ffffff;
font-weight: normal;
display: block;
padding: 0px 10px;
text-decoration: none;
}
ul#navigation-list a.navlink.active,
ul#navigation-list a.navlink:hover {
color: #ff0000;
}
div#home-main-image {
text-align: center;
background-color: #410000;
height:475px;
border-bottom:1px #000 solid;
}
div#the-content {
position:relative;
top:-19px;
} div#home-main-image img { /*width: 885px; height: 300px; margin-bottom: 20px; border-radius: 20px; */ } div.text-box { background: #444444; color: #ffffff; padding: 15px 20px; border-radius: 10px;
} div#footer-box { border-radius: 0 0 5px 5px; } #bodyContent { } #three-column { margin:0 auto; width:850px; margin-top:50px;
}
.col { text-align:justify; float:left; margin:5px; } .col h1 { font-size:14px; color:#000;
} /* hide native rubbish*/ #top-section {display:none; position:absolute; left:0px; top:-200px;} #top-section a { color:#FFF; } .firstHeading {display:none; position:absolute; left:0px; top:-200px;} .annoying-gap { padding:0px; margin:0px; line-height:0; }
#contentSub, #siteSub {display:none;}
#control-btn {
width: 20px; height: 20px; position:absolute; top:0px; left:5px;
line-height: 0px;
}
.btn-cog {
background: url('https://static.igem.org/mediawiki/2012/d/d4/Control-panel-sml.png') #000 no-repeat 2px 2px;
}
.btn-close {
background: url('https://static.igem.org/mediawiki/2012/d/d0/Close-btn.png') #000 no-repeat 2px 2px;
}
.right-menu li a, .left-menu li a {background: none}
</style>
<script type="text/javascript" src="http://code.jquery.com/jquery-1.8.2.min.js"></script> <script type="text/javascript"> $('document').ready(function() {
// menu $('li.submenu-holder').hover(function() { $(this).children('ul.submenu').stop(true).fadeIn('fast'); }, function() { $(this).children('ul.submenu').stop(true).fadeOut('fast'); });
// hide standard team basics
$('#top-section').hide();
$('#bodyContent p:first').addClass("annoying-gap");
$('#control-btn').click( function(){
if ($('#control-btn').hasClass("btn-cog")) { showTopMenu(); $('#control-btn').animate({left: "-20px"}); $('#control-btn').addClass("btn-close"); $('#control-btn').removeClass("btn-cog"); } else { hideTopMenu(); $('#control-btn').animate({left: "0px"}); $('#control-btn').addClass("btn-cog"); $('#control-btn').removeClass("btn-close"); } });
});
var $bar;
function hideTopMenu()
{
$bar.slideUp('fast');
} function showTopMenu() { if ($bar==null) { $bar = $("#top-section").clone(); $($bar.find("#search-controls")).remove(); $($bar.find("#p-logo")).remove(); $("#wrapper").prepend($bar); $bar.css("position", "absolute"); $bar.css("top", "0px"); $bar.css("left", "0px"); $bar.css("background", "none"); $bar.css("background", "rgba(0,0,0,.5)"); $bar.css("height", "20px"); $bar.css("border", "none"); $bar.css("z-index", "100"); $bar.css("color", "#000");
}
$bar.slideDown('fast');
$('#control-btn').mouseover( function(){
}); } </script> </head>
<body>
<a href="http://www.igem.org" title="iGEM homepage"><img src="" alt="iGEM logo" width="55" height="44" /></a>
<a href="https://2012.igem.org/Team:Westminster">
<img src="
" alt="iSTEM - intelligent synthetic tumour eliminating machine" width="172" height="66" title="iSTEM - intelligent synthetic tumour eliminating machine" />
</a>
Fighting cancer from the inside out
The Westminster iGEM 2012 team aims to combat cancer recurrence by using one key feature of CSCs – increased Aldehyde Dehydrogenase (ALDH) activity. We have used the promoters of 4 different ALDH isoforms present in aggressive forms of cancer to design 3 constucts that will allow us to identify, isolate and eliminate CSC, offering a novel tool for the study of this cells and a potential new anti-cancer therapy for the future.
<img src="
" alt="Tumor" width="218" height="179" />
<img src="" width="146" height="61"/>
<img src="" width="136" height="54"/>
<img src="" width="202" height="40"/>
<img src="" width="161" height="41"/>
<img src=""/>
</body>
